Nishinomiya, Japan

Giichi Hamada

This inventor holds 4 USPTO granted patents. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 1996-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giichi Hamada. Retrieved from https://idiyas.com/inventor/giichi-hamada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Giichi Hamada: Innovator in Pharmaceutical Composition

Introduction

Giichi Hamada is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on silicate polymers. With a total of four patents to his name, Hamada's inventions aim to enhance the functionality of living organisms by addressing various health issues.

Latest Patents

Hamada's latest patent focuses on a pharmaceutical composition that regulates the function of a living body. This invention provides silicate polymers that restore and normalize lowered cell functions due to diseases. The silicate polymers are designed to be water-soluble, with a molecular weight ranging from 4,800 to 2,000,000. The degree of polymerization varies from 75 to 33,000, with a preferred range of 490 to 16,500. The monomer unit utilized in these polymers is (SiO.sub.2). The production process involves dissolving a water-soluble silicate or silicic acid-containing material in water to create an aqueous solution. This solution can be adjusted to a pH of 2-10, preferably between 4-9.5, by adding an acid. Additionally, a saccharide, sugar alcohol, or pharmaceutically acceptable salt may be included. The final product can be dried to obtain a powder through heating or lyophilization. This pharmaceutical

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…